High Performance Thin Layer Chromatography method for analysis of 3,4-methylenedioxymethamphetamine in seized tablets

High Performance Thin Layer Chromatography method for analysis of 3,4-methylenedioxymethamphetamine in seized tablets

Context: Consumption of synthetic drugs had increased in recent years, used as a recreational drug by young people who presume that consumption of this drug is harmless for health; however clinical studies have shown that this stimulant and its metabolites are toxic. Due to these reasons, chemical a...

Full description

Bibliographic Details
Main Authors:	Boris E. Duffau, Sonia Rojas, Lorena A. Delgado, Sebastián Jofré
Format:	Article
Language:	English
Published:	GarVal Editorial Ltda. 2015-12-01
Series:	Journal of Pharmacy & Pharmacognosy Research
Subjects:	3 4-methylenedioxymethamphetamine ecstasy HPTLC MDMA
Online Access:	http://jppres.com/jppres/pdf/vol3/jppres15.096_3.6.162.pdf

Similar Items

Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation
by: Elena Puerta, et al.
Published: (2011-07-01)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
by: Ben Sessa, et al.
Published: (2019-03-01)

Acute medical problems due to Ecstasy use
by: I Kunz
Published: (2005-11-01)

Early onset Parkinson’s disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report
by: Tianyi Hui, et al.
Published: (2023-09-01)

Acute ascending aortic dissection after MDMA/ecstasy use: A case report
by: Satoko Kanahara, MD, et al.
Published: (2016-09-01)

Rare Variant of Lycanthropy and Ecstasy: Case Report
by: A KHeradmand, et al.
Published: (2008-09-01)

Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report
by: Kaeley Kaplan, et al.
Published: (2018-05-01)

The use of 3,4-Methylenedioxymethamphetamine (MDMA) in the treatment of Post-Traumatic Stress Disorder (PTSD) - review
by: Karol Womperski, et al.
Published: (2023-08-01)

Pharmacological Mechanisms Involved in Sensory Gating Disruption Induced by (±)-3,4-Methylene- Dioxymethamphetamine (MDMA): Relevance to Schizophrenia
by: Jaime Lee, et al.
Published: (2020-01-01)

MDMA-Assisted Therapy for Treatment-Resistant Posttraumatic Stress Disorder (PTSD) – One step further toward a patient-centered treatment pathway
by: S. Pratas Penedos, et al.
Published: (2022-06-01)

Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review
by: J. Sá Couto, et al.
Published: (2022-06-01)

Editorial: What is up with psychedelics anyway?
by: Candace R. Lewis, et al.
Published: (2023-03-01)

Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA (“Ecstasy”) in Rats and Preserves Affinity for the Serotonin Transporter (SERT)
by: Patricio Sáez-Briones, et al.
Published: (2019-02-01)

Sympathomimetic-Induced Hyperthermia and Hyponatremia: A Simulation Case for Emergency Medicine Residents
by: Ashlea Winfield, et al.
Published: (2021-01-01)

Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo
by: Paul J. Fitzgerald
Published: (2021-10-01)

Chemical Profile of Ecstasy Tablets – a Review
by: Emanuele Amorim Alves, et al.
Published: (2013-03-01)

Effect of 3,4-methylenedioxymethamphetamine on pituitary-gonadal hormonized axis in immature male Rats
by: Jamshidpoor L (BSc), et al.
Published: (2012-05-01)

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system
by: Tigran Makunts, et al.
Published: (2023-05-01)

Retrospective analysis of stimulant abuse cases reported to the Swiss Toxicological Information Centre during 1997–2009
by: M Bruggisser, et al.
Published: (2010-10-01)

Learning, Memory, and Executive Function in New MDMA Users: A Two-Year Follow-up Study
by: Daniel eWagner, et al.
Published: (2015-12-01)

Crime and Violence among MDMA Users in the United States
by: Michael G. Vaughn, et al.
Published: (2015-03-01)

Determinação de 3,4-metilenodioximetanfetamina (MDMA) em comprimidos de Ecstasy por cromatografia líquida de alta eficiência com detecção por fluorescência (CLAE-DF) Determination of 3,4-methylenedioxymethamphetamine (MDMA) in Ecstasy tablets by high performance liquid chromatography with fluorescence detection (HPLC-FD)
by: José Luiz da Costa, et al.
Published: (2009-01-01)

Aromatic Bromination Abolishes Deficits in Visuospatial Learning Induced by MDMA (“Ecstasy”) in Rats While Preserving the Ability to Increase LTP in the Prefrontal Cortex
by: Patricio Sáez-Briones, et al.
Published: (2023-02-01)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
by: João Paulo Capela, et al.
Published: (2022-01-01)

Effects of Repeated Administration of 3,4-methylenedioxymethamphetamine (MDMA) on Avoidance Memory and Cell Density in Rats\' Hippocampus
by: Mehrdad Jahanshahi, et al.
Published: (2013-02-01)

MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?
by: Rafael eDe La Torre, et al.
Published: (2012-11-01)

Memory impairment induced by amphetamine derivatives in laboratory animals and in humans: a review
by: Camarasa Jordi, et al.
Published: (2012-02-01)

Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy)
by: Shabnam Movassaghi, et al.
Published: (2013-08-01)

A New Method for Enantiomeric Determination of 3,4-Methylenedioxymethamphetamine and p-Methoxymethamphetamine in Human Urine
by: Wei-Jay Chen, et al.
Published: (2022-01-01)

Therapeutic effects of methimazole on 3,4-methylenedioxymethamphetamine-induced hyperthermia and serotonergic neurotoxicity
by: I-Hsun Li, et al.
Published: (2023-08-01)

Zingiber Officinale Alters 3,4-methylenedioxymethamphetamine-Induced Neurotoxicity in Rat Brain
by: Mehdi Mehdizadeh, et al.
Published: (2012-01-01)

Patterns of ecstasy use amongst live music event attendees and their opinions on pill testing: a cross sectional study
by: Madeleine Southey, et al.
Published: (2020-08-01)

Conflict monitoring and emotional processing in 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine users – A comparative neurophysiological study
by: Antje Opitz, et al.
Published: (2024-01-01)

Methylenedioxymethamphetamine (MDMA)-induced toxic leukoencephalopathy: a case report
by: Haitham Salem, et al.
Published: (2018-04-01)

Study the effect of 3,4-Methylenedioxy methamphetamine on cytochrome P450 2E1 activity
by: Shahin Nilchi, et al.
Published: (2022-12-01)

Differential sensitivity to detect prosocial effects of 3,4‐methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice
by: Satoko Mukai, et al.
Published: (2020-09-01)

Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand
by: Jai Whelan, et al.
Published: (2024-03-01)

Polyacrylonitrile Nanofiber-Based Quartz Crystal Microbalance for Sensitive Detection of Safrole
by: Aditya Rianjanu, et al.
Published: (2018-04-01)

Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice
by: V. Ferraz-de-Paula, et al.
Published: (2011-05-01)

Role of the gut–brain axis via the subdiaphragmatic vagus nerve in stress resilience of 3,4-methylenedioxymethamphetamine in mice exposed to chronic restrain stress
by: Youge Qu, et al.
Published: (2023-12-01)